Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors

被引：0
|
作者：
Aradhya Nigam
Janet W. Y. Li
Megan Fiasconaro
Sabrina Lin
Marinela Capanu
David A. Kleiman
Kelvin Memeh
Nitya Raj
Diane L. Reidy-Lagunes
Brian R. Untch
机构：
[1] Memorial Sloan Kettering Cancer Center,Department of Surgery
[2] Memorial Sloan Kettering Cancer Center,Department of Epidemiology and Statistics
[3] Lahey Hospital and Medical Center,Department of Surgery
[4] Memorial Sloan Kettering Cancer Center,Department of Medicine
来源：
Annals of Surgical Oncology | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2337 / 2348
页数：11
相关论文
共 50 条
  • [31] Metastatic well-differentiated pancreatic neuroendocrine tumors to the liver: a narrative review of systemic and surgical management
    Vaghaiwalla Tanaz
    Memeh Kelvin
    Liao Chih-Yi
    Keutgen Xavier M.
    胰腺病学杂志（英文）, 2021, 04 (02) : 82 - 89
  • [32] Metastatic well-differentiated pancreatic neuroendocrine tumors to the liver: a narrative review of systemic and surgical management
    Vaghaiwalla, Tanaz
    Memeh, Kelvin
    Liao, Chih-Yi
    Keutgen, Xavier M.
    JOURNAL OF PANCREATOLOGY, 2021, 4 (02) : 82 - 89
  • [33] Mesenteric Tumor Deposit Number, But Not Size, Affects Prognosis of Patients with Small Intestinal Well-Differentiated Neuroendocrine Tumors
    Gonzalez, Raul S.
    Cates, Justin
    Shi, Chanjuan
    MODERN PATHOLOGY, 2018, 31 : 265 - 265
  • [34] Mesenteric Tumor Deposit Number, But Not Size, Affects Prognosis of Patients with Small Intestinal Well-Differentiated Neuroendocrine Tumors
    Gonzalez, Raul S.
    Cates, Justin
    Shi, Chanjuan
    LABORATORY INVESTIGATION, 2018, 98 : 265 - 265
  • [35] Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?
    Gonzalez, Raul S.
    Liu, Eric H.
    Alvarez, JoAnn R.
    Ayers, Gregory D.
    Washington, M. Kay
    Shi, Chanjuan
    MODERN PATHOLOGY, 2014, 27 (09) : 1288 - 1295
  • [36] Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Dasari, Arvind
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [37] Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors
    Diane L Reidy
    Laura H Tang
    Leonard B Saltz
    Nature Reviews Clinical Oncology, 2009, 6 : 143 - 152
  • [38] Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors
    Liu, Alex J.
    Ueberroth, Benjamin E.
    McGarrah, Patrick W.
    Buckner Petty, Skye A.
    Kendi, Ayse Tuba
    Starr, Jason
    Hobday, Timothy J.
    Halfdanarson, Thorvardur R.
    Sonbol, Mohamad Bassam
    ONCOLOGIST, 2021, 26 (05): : 383 - 388
  • [39] Sarcopenia in Patients with Advanced Gastrointestinal Well-Differentiated Neuroendocrine Tumors
    Romano, Elena
    Polici, Michela
    Marasco, Matteo
    Lerose, Francesco
    Dell'Unto, Elisabetta
    Nardacci, Stefano
    Zerunian, Marta
    Iannicelli, Elsa
    Rinzivillo, Maria
    Laghi, Andrea
    Annibale, Bruno
    Panzuto, Francesco
    Caruso, Damiano
    NUTRIENTS, 2024, 16 (14)
  • [40] Consensus guidelines for the management of patients with digestive neuroendocrine tumors -: Well-differentiated jejunal-ileal tumor/carcinoma
    Eriksson, Barbro
    Kloeppel, Guenter
    Krenning, Eric
    Ahlman, Hakan
    Ploeckinger, Ursula
    Wiedenmann, Bertram
    Arnold, Rudolf
    Auernhammer, Christoph
    Koerner, Meike
    Rindi, Guido
    Wildi, Stefan
    NEUROENDOCRINOLOGY, 2008, 87 (01) : 8 - 19
12345